Manila wins 4 DOH newborn screening awards as UAE clinics face tighter screening rules

Manila has received four Department of Health (DOH) awards for its expanded newborn screening programme, including the Exemplary Local Government Unit Award, according to a Facebook news alert carried by Google News.

The item matters in the UAE because newborn screening is shifting from a laboratory task to a facility-level quality measure. The highest-stakes readers are COOs, medical directors and CFOs. COOs must prove that samples, consent and follow-up are completed on time. Medical directors carry the clinical risk when a treatable disorder is missed. CFOs need to know which items are covered by maternity packages or government programmes.

Why a Manila award matters in Dubai

The Manila announcement is outside the UAE, but its signal is local. Public recognition for newborn screening rewards the same capabilities that UAE regulators are now formalising: standard pathways, complete coverage, documented follow-up and named accountability. In Dubai, Dubai Health Authority (DHA) issued External Circular CIR-2026-00000172 on 6 October 2026 for the Newborn Screening Guideline, Version 1.0. The circular is addressed to all health professionals and health facilities under DHA jurisdiction.

Dubai maternity hospitals and outpatient clinics should treat that date as an operating trigger. The practical question is whether the facility can show, for every birth, the screening order, sample collection, result receipt, abnormal-result escalation and parental communication. A missed hand-off between the delivery unit, laboratory and paediatric follow-up clinic is now a compliance risk.

The UAE national direction predates the Dubai circular. Ministry of Health and Prevention (MOHAP) launched the National Newborn Screening Guidelines on 29 July 2024 for government and private hospitals. MOHAP said the guidelines standardise required laboratory and clinical tests and identify designated reference laboratories nationwide.

What operators should check this month

For clinics attached to maternity hospitals, the immediate work is process control. Abu Dhabi’s public materials say newborn examinations are recommended in the first stage after birth, 0-72 hours, and before hospital discharge. That timeframe is a useful benchmark for Dubai and the northern emirates, even where the local implementation document sets the detailed pathway.

• Dubai: check the DHA circular and attached guideline in Sheryan, then map each step to a named role.
• Abu Dhabi and Al Ain: check Department of Health – Abu Dhabi (DOH Abu Dhabi) newborn screening requirements and reporting systems.
• Northern emirates: check MOHAP guidance, especially reference laboratory arrangements and birth-facility obligations.
• Insurance: ask payers whether newborn screening is bundled, billed separately, or covered only for defined eligibility groups.

Price is the wrong place to guess. UAE facilities should obtain the current charge master item, payer pre-authorisation rule and maternity package schedule. Parents should ask whether the test is covered under the mother’s maternity benefit, the baby’s policy, Thiqa eligibility, or a government programme.

Abu Dhabi is moving beyond the heel-prick model

Abu Dhabi is the UAE market to watch because newborn screening is now linked to genomics. On 18 August 2025, DOH Abu Dhabi launched a Newborn Genetic Screening Programme using whole genome sequencing to screen for more than 815 treatable childhood genetic conditions. The first phase was implemented at Kanad Hospital and Danat Al Emarat Hospital in partnership with M42.

Abu Dhabi Public Health Centre says routine newborn screening in the UAE tests around 40 genetic and metabolic conditions. Its genetic screening programme is a standard part of care for eligible newborns in Abu Dhabi, covering UAE nationals and children of Emirati mothers born in the emirate. The cost of generating the genetic screening report is covered when the newborn is enrolled in the Emirati Genome Programme and at least one parent is a Thiqa cardholder, according to ADPHC programme information.

That creates a practical split for operators. Routine screening is a universal newborn safety pathway. Expanded genomic screening is an eligibility, consent, data and counselling pathway. CIOs should check whether electronic medical records can store consent, sample status, report availability and referral outcomes. Medical directors should define who explains abnormal findings and who owns the referral.

The Manila award is a reminder that newborn screening programmes are judged on execution. UAE clinics should review their DHA, DOH Abu Dhabi or MOHAP obligations now, then test one recent birth record from sample collection through parent notification. Patients looking for licensed maternity, paediatric and newborn screening providers can start with the UAE Open Healthcare Directory and confirm the facility’s licence with the relevant regulator.